دكتوراهClosing soon

Patient-derived protein corona-engineered bionanoarchitectures for personalized PDAC therapy

EURAXESS hosting organisation · عدة بلدان أوروبية

The candidate will need to have solid experience in oncological nanomedicine and cell and molecular biology, with particular reference to the development and preclinical evaluation of nanostructured systems for drug and gene delivery. Expertise is required in the preparation and physicochemical characterization of lipid nanoparticles and/or other nanocarriers, in the study of nano-bio interactions and protein corona, as well as in vitro evaluation by cell culture, viability/cytotoxicity assays, uptake and internalization, gene transfection and/or silencing, and expression analysis of molecular targets. Experience in in vivo preclinical studies, including evaluation of therapeutic efficacy, biodistribution and biological response in tumor animal models, is also required. Knowledge of animal

At a glance

Where: Multiple European countries
Deadline: 2026-09-25
Funding: Funding described on programme page
Board: EURAXESS

Who can apply

Criteria stated by the funder on the official source.

Nationality

EURAXESS vacancies rarely print a nationality table. Confirm whether applicants from Tunisia can apply and whether a residence/work permit pathway exists on the employer page.

غير مذكور

Education

Academic requirements are listed on the EURAXESS vacancy; match your degree level to the stated profile (often R1–R4).

غير مذكور

Funding and what it does not cover

Funding details were taken from the official programme page text. Confirm the current call before applying.